Puration Inc Confirms Cannabis Pharmaceutical Partnership Developments with Kali and Nouveau
October 31 2018 - 2:04PM
InvestorsHub NewsWire
Dallas, TX – October 31, 2017 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today
confirmed the developing joint venture agreement with Kali, Inc.
(USOTC: KALY) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV)
to develop cannabis pharmaceutical products. Puration further
confirms plans to host representatives from Kali and Nouvea in
Dallas next week to finalize JV details.
“Puration is already in the wellness
market and think our experience with the NCM Biotech Cannabis
extraction patent will be valuable to the JV,” said Brian Shibley
CEO of Puration. “I am pleased to be adding another dimension to
the valuation of Puration for shareholders by tangentially entering
the pharmaceuticals sector through a partnership while maintaining
our internal focus on cannabis infused beverages. I’m excited
to soon announce details on the new beverage we are adding through
acquisition. That announcement will be coming by Friday, if
not before, in a joint release from PURA and USMJ. To be
clear, the JV will be excluded from developing any beverages.
I’m not sure making a beverage would come up in a pharmaceutical
endeavor, by Puration’s participation requires the JV partners
agree that no beverage will be produced by the JV. Puration
is exclusively maintaining the cannabis beverage
opportunity.”
Kali, inc has schedule an online
presentation scheduled Friday, November 2nd, 2018 to
detail the strategy behind the recently announced JV
plans.
Kali Inc. To Present Strategy For Entering $50
Billion Cannabis Pharmaceutical Sector In Online Presentation This
Friday
Learn
more about Puration at https://www.purationinc.com/
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
Puration,
Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Sep 2023 to Sep 2024